TNFSF13B/BAFF Polyclonal antibody
TNFSF13B/BAFF Polyclonal Antibody for WB, IHC, ELISA
Host / Isotype
Rabbit / IgG
Reactivity
human, mouse, rat
Applications
WB, IHC, ELISA
Conjugate
Unconjugated
Cat no : 11862-1-AP
Synonyms
Validation Data Gallery
Tested Applications
Positive WB detected in | U-937 cells, mouse testis tissue, mouse liver tissue, human liver tissue, rat liver tissue |
Positive IHC detected in | human intrahepatic cholangiocarcinoma tissue Note: suggested antigen retrieval with TE buffer pH 9.0; (*) Alternatively, antigen retrieval may be performed with citrate buffer pH 6.0 |
Recommended dilution
Application | Dilution |
---|---|
Western Blot (WB) | WB : 1:500-1:2000 |
Immunohistochemistry (IHC) | IHC : 1:200-1:800 |
It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
Sample-dependent, Check data in validation data gallery. |
Product Information
11862-1-AP targets TNFSF13B/BAFF in WB, IHC, ELISA applications and shows reactivity with human, mouse, rat samples.
Tested Reactivity | human, mouse, rat |
Host / Isotype | Rabbit / IgG |
Class | Polyclonal |
Type | Antibody |
Immunogen | TNFSF13B/BAFF fusion protein Ag2440 相同性解析による交差性が予測される生物種 |
Full Name | tumor necrosis factor (ligand) superfamily, member 13b |
Calculated molecular weight | 32 kDa |
Observed molecular weight | 32 kDa, 45-52 kDa |
GenBank accession number | BC020674 |
Gene symbol | TNFSF13B |
Gene ID (NCBI) | 10673 |
RRID | AB_2303658 |
Conjugate | Unconjugated |
Form | Liquid |
Purification Method | Antigen affinity purification |
Storage Buffer | PBS with 0.02% sodium azide and 50% glycerol pH 7.3. |
Storage Conditions | Store at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. |
Background Information
TNFSF13B, also known as BAFF, BLYS, TALL1, TNFSF20, ZTNF4 and CD257, is a cytokine that binds to TNFRSF13B/TACI and TNFRSF17/BCMA. This cytokine is expressed in B lineage cells, and acts as a potent B cell activator. The BAFF system promotes B cell survival and differentiation and plays a prominent role in the pathogenesis of autoimmune diseases. It has been shown that BAFF inhibitors are in clinical trials for systemic lupus erythematosus with significant efficacy. This antibody recognizes all the forms of TNFSF13B such as soluble form (17 kDa), membrane form (32-35 kDa) and glycosylation form (45-52 kDa).
Protocols
Product Specific Protocols | |
---|---|
WB protocol for TNFSF13B/BAFF antibody 11862-1-AP | Download protocol |
IHC protocol for TNFSF13B/BAFF antibody 11862-1-AP | Download protocol |
Standard Protocols | |
---|---|
Click here to view our Standard Protocols |